\-\ Texto\\:\\ \ \(0\)\
\-\ nasal\\ mass\ \(10\)\
\-\ surgical\\ resection\\ followed\\ by\\ radiation\\ therapy\ \(0\)\
\-\ enhancing\\ mass\\ involving\\ right\\ side\\ of\\ nose\\,\\ right\\ ethmoid\\ sinuses\\,\\ and\\ extending\\ through\\ the\\ nasal\\ roof\\ into\\ the\\ anterior\\ \\(cribiform\\)\\ fossa\\.\ \(0\)\
\-\ olfactory\\ neuroblastoma\ \(0\)\
\-\ \\â\\€\\¢\\ inverting\\ papilloma\ \(1\)\
\-\ \\â\\€\\¢\\ olfactory\\ neuroblastoma\ \(0\)\
\-\ \\â\\€\\¢\\ neuroendocrine\\ tumor\ \(0\)\
\-\ \\â\\€\\¢\\ meningioma\ \(7\)\
\-\ \\â\\€\\¢\\ squamous\\ cell\\ carcinoma\ \(1\)\
\-\ \\â\\€\\¢\\ lymphoma\ \(6\)\
\-\ 38\\ year\\ old\\ woman\\ with\\ recurrent\\ nosebleeds\\ and\\ nasal\\ stuffiness\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ nasal\\:\\ 0\\.416046996252612\ \(0\)\
\-\ olfactory\\:\\ 0\\.3827555346325946\ \(0\)\
\-\ neuroblastoma\\:\\ 0\\.27951985659748374\ \(0\)\
\-\ stuffiness\\:\\ 0\\.22478504411506423\ \(0\)\
\-\ nosebleeds\\:\\ 0\\.2188345023349484\ \(0\)\
\-\ cribiform\\:\\ 0\\.20986183837010783\ \(0\)\
\-\ inverting\\:\\ 0\\.20035043128113786\ \(0\)\
\-\ neuroendocrine\\:\\ 0\\.19780880637799475\ \(0\)\
\-\ roof\\:\\ 0\\.1640574360612677\ \(0\)\
\-\ ethmoid\\:\\ 0\\.15908177121357203\ \(0\)\
\-\ nose\\:\\ 0\\.15393763275180233\ \(0\)\
\-\ sinuses\\:\\ 0\\.14328154874746687\ \(0\)\
\-\ papilloma\\:\\ 0\\.13948641946371984\ \(0\)\
\-\ squamous\\:\\ 0\\.13689536567219904\ \(0\)\
\-\ 38\\:\\ 0\\.13498977822306504\ \(0\)\
\-\ recurrent\\:\\ 0\\.12197215992724264\ \(0\)\
\-\ fossa\\:\\ 0\\.11941771132698065\ \(0\)\
\-\ mass\\:\\ 0\\.11620970407381738\ \(0\)\
\-\ meningioma\\:\\ 0\\.1139849892665118\ \(0\)\
\-\ involving\\:\\ 0\\.10654974683655465\ \(0\)\
\-\ side\\:\\ 0\\.10508712725154513\ \(0\)\
\-\ extending\\:\\ 0\\.10313766493938417\ \(0\)\
\-\ followed\\:\\ 0\\.10272314554152437\ \(0\)\
\-\ right\\:\\ 0\\.10086653882048542\ \(0\)\
\-\ radiation\\:\\ 0\\.10080574133425631\ \(0\)\
\-\ resection\\:\\ 0\\.09750934309529341\ \(0\)\
\-\ enhancing\\:\\ 0\\.09529258217144528\ \(0\)\
\-\ carcinoma\\:\\ 0\\.09098985659714064\ \(0\)\
\-\ lymphoma\\:\\ 0\\.09059543379658153\ \(0\)\
\-\ through\\:\\ 0\\.09055196699373069\ \(0\)\
\-\ therapy\\:\\ 0\\.08740141151786376\ \(0\)\
\-\ cell\\:\\ 0\\.08701826013273246\ \(0\)\
\-\ anterior\\:\\ 0\\.08493356367653973\ \(0\)\
\-\ into\\:\\ 0\\.08086308307348318\ \(0\)\
\-\ tumor\\:\\ 0\\.07956631641497902\ \(0\)\
\-\ woman\\:\\ 0\\.07922332933759932\ \(0\)\
\-\ surgical\\:\\ 0\\.07393410251046384\ \(0\)\
\-\ by\\:\\ 0\\.06459794387901202\ \(0\)\
\-\ and\\:\\ 0\\.0628664681448513\ \(0\)\
\-\ the\\:\\ 0\\.06070593544942481\ \(0\)\
\-\ year\\:\\ 0\\.04687964103055096\ \(0\)\
\-\ old\\:\\ 0\\.04502068317978983\ \(0\)\
\-\ with\\:\\ 0\\.029786522525794508\ \(0\)\
\-\ of\\:\\ 0\\.02976873571329931\ \(0\)\
